Stay updated on the latest developments in the ophthalmology industry with Becker's 2024 report, featuring breakthroughs, studies, and more!

Surgeon's Point Surgery Center in Cedar Park, Texas, is the first ASC in the world to utilize Moon Surgical's Maestro System, a digital surgical assistant.

The U.S. 2nd Court of Appeals recently revisited a whistleblower lawsuit against Novartis, a Swiss pharmaceutical company, creating a new development in the enforcement of the Anti-Kickback Statute, ...

Laurel, Va.-based Virginia Care Partners, an affiliate of HCA Virginia in Richmond, has established a partnership with Pearl Health, a technology platform geared specifically toward independent ...

Former Charleston physician sentenced to prison for illegal distribution of oxycodone. Learn about the case and the consequences for Dr. Otellin.

A Jan. 7 bipartisan Senate report titled "Profits Over Patients: The Harmful Effects of Private Equity on the U.S. Health Care System" heavily scrutinized private equity involvement in healthcare, ...

From prior authorization burdens to the advent of new AI, three gastroenterology specialists spoke with Becker's about the key factors that will make or break the field of GI in 2025.

Lewiston-based Central Maine Healthcare will be acquired by Ontario, Calif.-based Prime Healthcare Foundation pending regulatory approval, WMTW reported Jan. 8.

The Lina Khan-led Federal Trade Commission is making one final attempt to secure a ban on worker noncompete agreements just weeks before President-elect Donald Trump is sworn in, which is expected to ...

Nathan Starke, MD, a former urologist at Houston Methodist Hospital, was temporarily suspended without notice Dec. 20, according to a Jan. 7 news release from the Texas Medical Board. The board's ...

Even in CON-restricted states, cardiac catheterization labs are gaining momentum. In Virginia, for example, Richmond-based Virginia Cardiovascular Specialists recently opened the state's first ...

Here are five notes on where Walgreens stands in 2025: 1. Walgreens could sell itself to private equity firm Sycamore Partners and become private in 2025, The Wall Street Journal reported Dec. 10.